Overview of Allergy and Anaphylaxis.
Anaphylaxis
Diagnosis
Epidemiology
Epinephrine
Risk factors
Journal
Immunology and allergy clinics of North America
ISSN: 1557-8607
Titre abrégé: Immunol Allergy Clin North Am
Pays: United States
ID NLM: 8805635
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
medline:
4
7
2023
pubmed:
3
7
2023
entrez:
2
7
2023
Statut:
ppublish
Résumé
Allergic reactions and anaphylaxis occur on a severity continuum from mild and self-limited to potentially life-threatening or fatal reactions. Anaphylaxis is typically a multiorgan phenomenon involving a broad range of effector cells and mediators. Emergency department visits for anaphylaxis are increasing, especially among children. There is a broad differential diagnosis for anaphylaxis, and the diagnosis of anaphylaxis can be aided by the use of the National Institutes of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network clinical diagnostic criteria. Risk factors for severe anaphylaxis include older age, delayed epinephrine administration, and cardiopulmonary comorbidities.
Identifiants
pubmed: 37394251
pii: S0889-8561(22)00906-7
doi: 10.1016/j.iac.2022.10.009
pii:
doi:
Substances chimiques
Epinephrine
YKH834O4BH
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
435-451Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure Dr. Campbell is an author for UpToDate and a consultant for Bryn Pharma. Dr. Dribin has received research funding from the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number 2UL1TR001425-05A1 and Award Number 2KL2TR001426-05A1.